These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33991705)

  • 1. Total IgE Variability Is Associated with Future Asthma Exacerbations: A 1-Year Prospective Cohort Study.
    Yuan YL; Zhang X; Liu L; Wang G; Chen-Yu Hsu A; Huang D; Wang G; Oliver BG
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2812-2824. PubMed ID: 33991705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrasubject Variability in Total IgE Levels in Patients with Moderate to Severe Persistent Allergic Asthma Over 1 Year.
    Hatipoğlu U; Subramanian A; Campbell T; Rice R; Mummadi S; Hu B; Lang DM
    J Allergy Clin Immunol Pract; 2016; 4(4):691-696.e1. PubMed ID: 27039239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
    Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
    Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Liu L; Zhang X; Liu Y; Zhang L; Zheng J; Wang J; Hansbro PM; Wang L; Wang G; Hsu AC
    Respir Res; 2019 May; 20(1):95. PubMed ID: 31113430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
    Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
    Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Reported Insufficient Sleep Is Associated With Clinical and Inflammatory Features of Asthma: A Prospective Cohort Study.
    Wang CY; Wang J; Zhang L; Zhang SW; Wang L; Zhao SZ; Chen ZH; Zhang X; Xie M; Wang T; Chen-Yu Hsu A; Qin L; Oliver BG; Liu L; Wan HJ; Liu D; Luo FM; Li WM; Wang G
    J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1200-1210.e4. PubMed ID: 36581067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeostatic Measure of Insulin Resistance Is Associated With Future Asthma Exacerbations: A 1-Year Prospective Cohort Study.
    Gao SY; Deng K; Wang J; Jin FD; Huang YL; Chen ZH; Oliver BG; Xie M; Wan HJ; Qin L; Liu D; Luo FM; Chen-Yu Hsu A; Li WM; Wang G; Wood LG
    J Allergy Clin Immunol Pract; 2024 Oct; 12(10):2774-2784.e3. PubMed ID: 38944198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study.
    Dal Negro RW; Guerriero M; Micheletto C; Tognella S; Visconti M
    J Asthma; 2011 Jun; 48(5):437-41. PubMed ID: 21599560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study.
    Deng K; Zhang X; Liu Y; Cheng GP; Zhang HP; Wang T; Wang L; Li WM; Wang G; Wood L
    Allergy Asthma Proc; 2020 Sep; 41(5):348-356. PubMed ID: 32867889
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma.
    Semprini R; Williams M; Semprini A; McDouall A; Fingleton J; Holweg C; Weatherall M; Beasley R; Braithwaite I
    J Allergy Clin Immunol Pract; 2018; 6(6):1982-1988.e1. PubMed ID: 29609049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Haughney J; Morice A; Blyth KG; Lee AJ; Coutts A; McKnight E; Pavord I
    Respir Med; 2018 Jan; 134():117-123. PubMed ID: 29413497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J; Cabrera P; Berkman N; Buhl R; Holgate S; Wenzel S; Fox H; Hedgecock S; Blogg M; Cioppa GD
    Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and persistence of childhood asthma: predictors from infancy.
    Klinnert MD; Nelson HS; Price MR; Adinoff AD; Leung DY; Mrazek DA
    Pediatrics; 2001 Oct; 108(4):E69. PubMed ID: 11581477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly.
    Song WJ; Sintobin I; Sohn KH; Kang MG; Park HK; Jo EJ; Lee SE; Yang MS; Kim SH; Park HK; Kwon YE; Kim TB; Kim SH; Park HW; Chang YS; Lee BJ; Jee YK; Choi BW; Bachert C; Cho SH
    Clin Exp Allergy; 2016 Mar; 46(3):411-21. PubMed ID: 26436720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia Is Associated With Worse Asthma Clinical Outcomes: A Prospective Cohort Study.
    Liu L; Liu Y; Zhang X; Yuan YL; Chen ZH; Chen-Yu Hsu A; Oliver BG; Xie M; Qin L; Li WM; Liu D; Wang G; Wood LG
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):863-872.e8. PubMed ID: 36535523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal increase in total IgE levels in patients with adult asthma: an association with poor asthma control.
    Tanaka A; Jinno M; Hirai K; Miyata Y; Mizuma H; Yamaguchi M; Ohta S; Watanabe Y; Yamamoto M; Suzuki S; Yokoe T; Adachi M; Sagara H
    Respir Res; 2014 Nov; 15(1):144. PubMed ID: 25409901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
    Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
    Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.